Technology Partners

Technology Partners is a venture capital firm founded in 1980 and headquartered in Novato, California. The firm specializes in seed, early, and later-stage investments, focusing primarily on companies in the clean technology and life science sectors. With decades of experience, Technology Partners seeks to support innovative businesses that address critical challenges within these industries.

Roger Quy Ph.D

General Partner

82 past transactions

Benvenue Medical

Series F in 2016
Benvenue Medical, Inc. is a company specializing in the design, manufacture, and marketing of minimally invasive expandable implant systems for the treatment of spinal disorders, specifically vertebral compression fractures and degenerative disc diseases. Its product offerings include the Kiva system, which addresses spinal fractures in the thoracic and lumbar regions, and the Blazer – C system, designed for treating pathological vertebral compression fractures. Additionally, Benvenue Medical has introduced the Luna 3D, an expandable interbody fusion system suitable for various surgical approaches. The company serves a diverse customer base across the United States, Canada, Belgium, France, and Germany. Founded in 2004, Benvenue Medical is headquartered in Santa Clara, California, and is focused on developing innovative surgical solutions that enhance patient outcomes and restore spinal alignment.

Elcelyx Therapeutics

Series E in 2015
Elcelyx Therapeutics, founded in 2010 and headquartered in San Diego, California, focuses on developing innovative treatments for diabetes and obesity-related metabolic disorders through its proprietary Gut Sensory Modulation (GSM) technology. The company's lead product candidate, NewMet, is designed to improve glucose metabolism by amplifying hormone release in the lower gut, thereby addressing significant unmet needs in the oral anti-diabetic market. Currently entering Phase 2b development, NewMet represents a potential breakthrough in diabetes management. Elcelyx also offers Lovidia, which targets similar metabolic issues without causing systemic side effects. The company is supported by a skilled management team, experienced investors, and a network of scientists and clinicians. In 2013, Elcelyx established NaZura BioHealth Inc. to focus on developing additional non-NewMet assets, further expanding its research and product pipeline.

Beamreach

Series D in 2015
Beamreach Solar focuses on the development of high-efficiency, low-cost crystalline silicon solar cells and modules for photovoltaic electricity generation. The company utilizes an innovative, proprietary cell architecture to enhance the sunlight capture and conversion efficiency of mono-crystalline silicon materials. This approach not only improves the performance of their solar panels but also aims to make clean energy more affordable and accessible. By optimizing the design, Beamreach enables solar installers and commercial building owners to reduce installation time and labor costs associated with traditional solar panels and racking systems.

Kaiam

Venture Round in 2014
Kaiam is a manufacturer of optical components for high-speed data transfer in data centers. The company designs and produces photonic integrated circuits, planar light wave circuits, optical sub-assemblies, modules and transceivers for fiber optic communications, delivering optical networking products to data centers and related applications.

Beamreach

Series D in 2014
Beamreach Solar focuses on the development of high-efficiency, low-cost crystalline silicon solar cells and modules for photovoltaic electricity generation. The company utilizes an innovative, proprietary cell architecture to enhance the sunlight capture and conversion efficiency of mono-crystalline silicon materials. This approach not only improves the performance of their solar panels but also aims to make clean energy more affordable and accessible. By optimizing the design, Beamreach enables solar installers and commercial building owners to reduce installation time and labor costs associated with traditional solar panels and racking systems.

Benvenue Medical

Series E in 2014
Benvenue Medical, Inc. is a company specializing in the design, manufacture, and marketing of minimally invasive expandable implant systems for the treatment of spinal disorders, specifically vertebral compression fractures and degenerative disc diseases. Its product offerings include the Kiva system, which addresses spinal fractures in the thoracic and lumbar regions, and the Blazer – C system, designed for treating pathological vertebral compression fractures. Additionally, Benvenue Medical has introduced the Luna 3D, an expandable interbody fusion system suitable for various surgical approaches. The company serves a diverse customer base across the United States, Canada, Belgium, France, and Germany. Founded in 2004, Benvenue Medical is headquartered in Santa Clara, California, and is focused on developing innovative surgical solutions that enhance patient outcomes and restore spinal alignment.

ForSight Labs

Series C in 2014
ForSight Labs is a company dedicated to developing innovative ophthalmic technologies aimed at improving the sight, care, and quality of life for visually impaired patients. With a focus on addressing the significant challenges posed by vision loss, including conditions like glaucoma, ForSight Labs collaborates with a team of motivated professionals, clinicians, and investors to bring new solutions to the ophthalmic community. The company recognizes the profound impact of vision impairment on individuals and society, as the number of people suffering from visual impairment is expected to increase significantly in the coming years. By driving the development and commercialization of high-impact eye care technologies, ForSight Labs aims to deliver effective treatments that enhance patient outcomes and address the substantial economic burden associated with vision loss.

ForSight VISION5

Series C in 2014
ForSight VISION5, founded in 2010 as part of ForSight Labs, specializes in the development of non-invasive drug delivery technologies aimed at treating major eye diseases such as glaucoma, dry eye, and allergies. The company is focused on creating innovative products that can replace traditional eye drops and offer sustained therapeutic effects. Currently, ForSight VISION5 is advancing its lead product, the Helios insert, which is undergoing its second Phase 2 clinical study, reflecting the company's commitment to improving patient care in ophthalmology through effective and patient-friendly solutions.

Transcend Medical

Series C in 2014
Transcend Medical, Inc. is an ophthalmic device company based in Menlo Park, California, focused on developing innovative medical devices for the treatment of glaucoma, a leading cause of irreversible blindness in adults. Founded in 2005, Transcend Medical emerged from ForSight Labs, an incubator dedicated to ophthalmic innovations. The company's flagship product, the CyPass Micro-Stent, is a micro-invasive device designed to be implanted during routine cataract surgery to reduce intraocular pressure. Additionally, Transcend Medical offers the Vold Gonio Lens for use in micro-invasive glaucoma surgeries and provides clinical trial services. The CyPass Micro-Stent received its CE mark in 2008 and has been undergoing evaluation in various clinical studies, including the COMPASS multi-center trial, to assess its effectiveness and safety in treating glaucoma. As of 2016, Transcend Medical operates as a subsidiary of Alcon Holdings, Inc.

Elcelyx Therapeutics

Series C in 2014
Elcelyx Therapeutics, founded in 2010 and headquartered in San Diego, California, focuses on developing innovative treatments for diabetes and obesity-related metabolic disorders through its proprietary Gut Sensory Modulation (GSM) technology. The company's lead product candidate, NewMet, is designed to improve glucose metabolism by amplifying hormone release in the lower gut, thereby addressing significant unmet needs in the oral anti-diabetic market. Currently entering Phase 2b development, NewMet represents a potential breakthrough in diabetes management. Elcelyx also offers Lovidia, which targets similar metabolic issues without causing systemic side effects. The company is supported by a skilled management team, experienced investors, and a network of scientists and clinicians. In 2013, Elcelyx established NaZura BioHealth Inc. to focus on developing additional non-NewMet assets, further expanding its research and product pipeline.

Kaiam

Venture Round in 2013
Kaiam is a manufacturer of optical components for high-speed data transfer in data centers. The company designs and produces photonic integrated circuits, planar light wave circuits, optical sub-assemblies, modules and transceivers for fiber optic communications, delivering optical networking products to data centers and related applications.

Beamreach

Series C in 2013
Beamreach Solar focuses on the development of high-efficiency, low-cost crystalline silicon solar cells and modules for photovoltaic electricity generation. The company utilizes an innovative, proprietary cell architecture to enhance the sunlight capture and conversion efficiency of mono-crystalline silicon materials. This approach not only improves the performance of their solar panels but also aims to make clean energy more affordable and accessible. By optimizing the design, Beamreach enables solar installers and commercial building owners to reduce installation time and labor costs associated with traditional solar panels and racking systems.

CoalTek

Convertible Note in 2013
CoalTek, Inc. specializes in the production of high-quality coal by converting lower-grade coal into a cleaner energy fuel with reduced environmental impact. Founded in 1998 and headquartered in Tucker, Georgia, the company employs a proprietary volumetric heating process that targets moisture within the coal, utilizing 50-70 percent less energy compared to traditional thermal methods. This technology, developed over eight years by co-founder Dr. Jerry Weinberg and chief geologist Neil Ginther, effectively reduces the moisture content in various types of coal, enhancing plant efficiency and ensuring compliance with environmental standards. CoalTek opened its first commercial processing facility in Calvert City, Kentucky, in 2006, with an initial capacity of 120,000 tons per year, and plans for future expansions and additional facilities to meet the increasing demand for clean coal solutions.

ForSight Labs

Series B in 2013
ForSight Labs is a company dedicated to developing innovative ophthalmic technologies aimed at improving the sight, care, and quality of life for visually impaired patients. With a focus on addressing the significant challenges posed by vision loss, including conditions like glaucoma, ForSight Labs collaborates with a team of motivated professionals, clinicians, and investors to bring new solutions to the ophthalmic community. The company recognizes the profound impact of vision impairment on individuals and society, as the number of people suffering from visual impairment is expected to increase significantly in the coming years. By driving the development and commercialization of high-impact eye care technologies, ForSight Labs aims to deliver effective treatments that enhance patient outcomes and address the substantial economic burden associated with vision loss.

ForSight VISION5

Series B in 2013
ForSight VISION5, founded in 2010 as part of ForSight Labs, specializes in the development of non-invasive drug delivery technologies aimed at treating major eye diseases such as glaucoma, dry eye, and allergies. The company is focused on creating innovative products that can replace traditional eye drops and offer sustained therapeutic effects. Currently, ForSight VISION5 is advancing its lead product, the Helios insert, which is undergoing its second Phase 2 clinical study, reflecting the company's commitment to improving patient care in ophthalmology through effective and patient-friendly solutions.

Scioderm

Series A in 2013
Scioderm, LLC is a clinical-stage pharmaceutical company based in Durham, North Carolina, specializing in the research, development, and manufacturing of drugs for chronic skin diseases, particularly epidermolysis bullosa (EB). The company is focused on creating topical therapies to meet critical medical needs in dermatology. Its lead product, Zorblisa, is an investigational therapy aimed at treating the skin blistering and lesions associated with EB, a rare genetic disorder characterized by fragile skin. Zorblisa promotes the healing of existing skin lesions and aims to reduce the incidence and severity of new lesions. Founded in 2012, Scioderm operates as a subsidiary of Amicus Therapeutics, Inc.

Tonix Pharmaceuticals Holding

Post in 2012
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and licensing of small molecules and biologics aimed at treating and preventing human diseases. The company has two primary portfolios: immunology and central nervous system (CNS). The immunology portfolio includes vaccines and biologics designed to combat infectious diseases, immunosuppression, cancer, and autoimmune disorders. Notable vaccine candidates include TNX-1800, a live replicating vaccine for COVID-19, and TNX-801, a vaccine for smallpox and monkeypox. The CNS portfolio features therapies for pain, neurological, psychiatric, and addiction conditions, including TNX-102 SL, which is in Phase 3 for fibromyalgia management. Other candidates in development target cocaine intoxication, depression, and migraine treatment. Additionally, Tonix is advancing several preclinical candidates aimed at conditions such as post-traumatic stress disorder and organ transplant rejection. Founded in 2007 and based in New York, Tonix is committed to alleviating suffering through innovative therapeutic solutions.

Tria Beauty

Venture Round in 2012
TRIA Beauty, Inc. is a developer and marketer of light-based medical devices aimed at the consumer market, specializing in beauty and skincare solutions. Founded in 2003 and headquartered in Dublin, California, the company offers a range of innovative products including a hand-held, cordless diode laser for hair removal, a Skin Perfecting Blue Light device for acne treatment, a Skin Rejuvenating Laser for anti-aging purposes, and an Age-Defying Eye Wrinkle Correcting Laser. These devices utilize advanced light technology, which is preferred by dermatologists for effective skincare treatments, allowing users to achieve professional results at home. TRIA Beauty products are available through its e-commerce platform and various indirect sales channels, including retail outlets, television, and physician offices. The company serves a global market, reaching customers in the United States, Japan, South Korea, Canada, the United Kingdom, Germany, and Spain.

Akros Silicon

Venture Round in 2012
Akros Silicon Inc. is a fabless semiconductor company specializing in the development of power management integrated circuits (ICs) aimed at facilitating remote, network-based energy management. Founded in 2005 and based in San Jose, California, with an additional office in Shanghai, the company utilizes precision analog and mixed-signal CMOS technologies to create system-level solutions. Its product offerings include isolated DC-DC system-on-chip solutions, power-over-Ethernet powered device controllers, digital isolators, and intelligent energy management ICs. These solutions are designed to support a variety of applications, including Ethernet switches, routers, solar microinverters, VoIP phones, wireless LAN access points, and various industrial and medical equipment. Akros Silicon's innovative technology, such as its GreenEdge digital isolation, enhances the integration and efficiency of power systems, contributing to global green power management initiatives.

Elcelyx Therapeutics

Series B in 2012
Elcelyx Therapeutics, founded in 2010 and headquartered in San Diego, California, focuses on developing innovative treatments for diabetes and obesity-related metabolic disorders through its proprietary Gut Sensory Modulation (GSM) technology. The company's lead product candidate, NewMet, is designed to improve glucose metabolism by amplifying hormone release in the lower gut, thereby addressing significant unmet needs in the oral anti-diabetic market. Currently entering Phase 2b development, NewMet represents a potential breakthrough in diabetes management. Elcelyx also offers Lovidia, which targets similar metabolic issues without causing systemic side effects. The company is supported by a skilled management team, experienced investors, and a network of scientists and clinicians. In 2013, Elcelyx established NaZura BioHealth Inc. to focus on developing additional non-NewMet assets, further expanding its research and product pipeline.

Beamreach

Series C in 2012
Beamreach Solar focuses on the development of high-efficiency, low-cost crystalline silicon solar cells and modules for photovoltaic electricity generation. The company utilizes an innovative, proprietary cell architecture to enhance the sunlight capture and conversion efficiency of mono-crystalline silicon materials. This approach not only improves the performance of their solar panels but also aims to make clean energy more affordable and accessible. By optimizing the design, Beamreach enables solar installers and commercial building owners to reduce installation time and labor costs associated with traditional solar panels and racking systems.

Benvenue Medical

Series D in 2012
Benvenue Medical, Inc. is a company specializing in the design, manufacture, and marketing of minimally invasive expandable implant systems for the treatment of spinal disorders, specifically vertebral compression fractures and degenerative disc diseases. Its product offerings include the Kiva system, which addresses spinal fractures in the thoracic and lumbar regions, and the Blazer – C system, designed for treating pathological vertebral compression fractures. Additionally, Benvenue Medical has introduced the Luna 3D, an expandable interbody fusion system suitable for various surgical approaches. The company serves a diverse customer base across the United States, Canada, Belgium, France, and Germany. Founded in 2004, Benvenue Medical is headquartered in Santa Clara, California, and is focused on developing innovative surgical solutions that enhance patient outcomes and restore spinal alignment.

Beamreach

Series C in 2012
Beamreach Solar focuses on the development of high-efficiency, low-cost crystalline silicon solar cells and modules for photovoltaic electricity generation. The company utilizes an innovative, proprietary cell architecture to enhance the sunlight capture and conversion efficiency of mono-crystalline silicon materials. This approach not only improves the performance of their solar panels but also aims to make clean energy more affordable and accessible. By optimizing the design, Beamreach enables solar installers and commercial building owners to reduce installation time and labor costs associated with traditional solar panels and racking systems.

Transcend Medical

Series B in 2012
Transcend Medical, Inc. is an ophthalmic device company based in Menlo Park, California, focused on developing innovative medical devices for the treatment of glaucoma, a leading cause of irreversible blindness in adults. Founded in 2005, Transcend Medical emerged from ForSight Labs, an incubator dedicated to ophthalmic innovations. The company's flagship product, the CyPass Micro-Stent, is a micro-invasive device designed to be implanted during routine cataract surgery to reduce intraocular pressure. Additionally, Transcend Medical offers the Vold Gonio Lens for use in micro-invasive glaucoma surgeries and provides clinical trial services. The CyPass Micro-Stent received its CE mark in 2008 and has been undergoing evaluation in various clinical studies, including the COMPASS multi-center trial, to assess its effectiveness and safety in treating glaucoma. As of 2016, Transcend Medical operates as a subsidiary of Alcon Holdings, Inc.

Medley Health

Series A in 2011
Medley Health is an innovative, entrepreneurial, technology-driven company. It's backed by top-tier investors and a management team with deep business expertise in healthcare, Internet and web services, as well as next-generation communications technologies.

Transcend Medical

Series B in 2011
Transcend Medical, Inc. is an ophthalmic device company based in Menlo Park, California, focused on developing innovative medical devices for the treatment of glaucoma, a leading cause of irreversible blindness in adults. Founded in 2005, Transcend Medical emerged from ForSight Labs, an incubator dedicated to ophthalmic innovations. The company's flagship product, the CyPass Micro-Stent, is a micro-invasive device designed to be implanted during routine cataract surgery to reduce intraocular pressure. Additionally, Transcend Medical offers the Vold Gonio Lens for use in micro-invasive glaucoma surgeries and provides clinical trial services. The CyPass Micro-Stent received its CE mark in 2008 and has been undergoing evaluation in various clinical studies, including the COMPASS multi-center trial, to assess its effectiveness and safety in treating glaucoma. As of 2016, Transcend Medical operates as a subsidiary of Alcon Holdings, Inc.

Revance Therapeutics

Series D in 2011
Revance Therapeutics is a biopharmaceutical company focused on developing and commercializing products for dermatology and aesthetics. Its lead product, RT001, is a topical botulinum toxin type A for cosmetic use, hyperhidrosis treatment, and other dermatological indications.

Benvenue Medical

Series C in 2011
Benvenue Medical, Inc. is a company specializing in the design, manufacture, and marketing of minimally invasive expandable implant systems for the treatment of spinal disorders, specifically vertebral compression fractures and degenerative disc diseases. Its product offerings include the Kiva system, which addresses spinal fractures in the thoracic and lumbar regions, and the Blazer – C system, designed for treating pathological vertebral compression fractures. Additionally, Benvenue Medical has introduced the Luna 3D, an expandable interbody fusion system suitable for various surgical approaches. The company serves a diverse customer base across the United States, Canada, Belgium, France, and Germany. Founded in 2004, Benvenue Medical is headquartered in Santa Clara, California, and is focused on developing innovative surgical solutions that enhance patient outcomes and restore spinal alignment.

Alta Devices

Private Equity Round in 2011
Alta Devices, Inc. is a manufacturer of innovative solar technology specializing in single junction solar cells. Founded in 2007 and based in Sunnyvale, California, the company develops thin and flexible mobile power solutions designed for a variety of applications, including unmanned systems, consumer electronics, sensors, automotive, remote exploration, wearables, and Internet of Things devices. Alta Devices aims to enhance the production economics of high-efficiency solar photovoltaic applications, positioning itself at the forefront of solar energy advancements. As of 2015, the company operates as a subsidiary of Hanergy Hi-Tech Power (HK) Limited.

Tria Beauty

Venture Round in 2011
TRIA Beauty, Inc. is a developer and marketer of light-based medical devices aimed at the consumer market, specializing in beauty and skincare solutions. Founded in 2003 and headquartered in Dublin, California, the company offers a range of innovative products including a hand-held, cordless diode laser for hair removal, a Skin Perfecting Blue Light device for acne treatment, a Skin Rejuvenating Laser for anti-aging purposes, and an Age-Defying Eye Wrinkle Correcting Laser. These devices utilize advanced light technology, which is preferred by dermatologists for effective skincare treatments, allowing users to achieve professional results at home. TRIA Beauty products are available through its e-commerce platform and various indirect sales channels, including retail outlets, television, and physician offices. The company serves a global market, reaching customers in the United States, Japan, South Korea, Canada, the United Kingdom, Germany, and Spain.

Incline Therapeutics

Series A in 2010
Incline Therapeutics is a privately-held specialty pharmaceutical company that concentrates on developing innovative pain management solutions for hospital settings. The company's primary focus is on IONSYS, a fentanyl iontophoretic transdermal system designed as a patient-controlled analgesia option for adult inpatients who require opioid pain relief following surgery. This system offers a compact and disposable approach, utilizing a needleless design for the short-term management of postoperative pain. Incline Therapeutics is backed by prominent life science venture capital firms and is guided by an experienced management team with considerable expertise in the pharmaceutical and medical device industries.

Revance Therapeutics

Series D in 2009
Revance Therapeutics is a biopharmaceutical company focused on developing and commercializing products for dermatology and aesthetics. Its lead product, RT001, is a topical botulinum toxin type A for cosmetic use, hyperhidrosis treatment, and other dermatological indications.

EmSense

Series C in 2009
EmSense Corporation provides scalable physiological and brainwave measurement technology. Its EmSense headset measures brainwave cognition and emotion on a moment by moment basis as consumers are exposed to advertising, video games, political messaging, movies, and TV shows, as well as incorporates physiological sensors that measure viewers' blinking, breathing, and physical motion to their heart activity and moments when they blush. The company was founded in 2004 and is based in San Francisco, California with additional offices in Monterey and Santa Monica, California.

Transcend Medical

Series B in 2009
Transcend Medical, Inc. is an ophthalmic device company based in Menlo Park, California, focused on developing innovative medical devices for the treatment of glaucoma, a leading cause of irreversible blindness in adults. Founded in 2005, Transcend Medical emerged from ForSight Labs, an incubator dedicated to ophthalmic innovations. The company's flagship product, the CyPass Micro-Stent, is a micro-invasive device designed to be implanted during routine cataract surgery to reduce intraocular pressure. Additionally, Transcend Medical offers the Vold Gonio Lens for use in micro-invasive glaucoma surgeries and provides clinical trial services. The CyPass Micro-Stent received its CE mark in 2008 and has been undergoing evaluation in various clinical studies, including the COMPASS multi-center trial, to assess its effectiveness and safety in treating glaucoma. As of 2016, Transcend Medical operates as a subsidiary of Alcon Holdings, Inc.

Visiogen

Series D in 2009
Visiogen, Inc. is an ophthalmic medical device company focused on creating innovative vision solutions for cataract patients, including those with presbyopia. The company's flagship product is the Synchrony dual optic accommodating intraocular lens (IOL), designed to deliver a seamless vision experience across near, intermediate, and distance ranges without the need for corrective eyewear. To enhance surgical efficiency, the Synchrony IOL is supplied in a pre-loaded injector, minimizing lens handling during procedures. This advanced technology has received CE Mark approval in Europe and is currently undergoing clinical trials in the United States, reflecting Visiogen's commitment to improving patient outcomes in cataract surgery.

PowerGenix

Funding Round in 2008
PowerGenix is a manufacturer of nickel-zinc rechargeable batteries designed for mission-critical applications. The company's products are utilized in a variety of sectors, including data centers, intelligent transportation, cordless power tools, hybrid electric vehicles, uninterruptible power supply (UPS) systems, personal mobility devices, and military and medical devices. By focusing on sustainable battery technology, PowerGenix aims to provide reliable and efficient power solutions for diverse applications, contributing to advancements in energy storage and management.

Abound Solar

Venture Round in 2008
Abound Solar produces next-generation, thin film photovoltaic modules intended to deliver the lowest levelized cost of electricity.

Beamreach

Series B in 2008
Beamreach Solar focuses on the development of high-efficiency, low-cost crystalline silicon solar cells and modules for photovoltaic electricity generation. The company utilizes an innovative, proprietary cell architecture to enhance the sunlight capture and conversion efficiency of mono-crystalline silicon materials. This approach not only improves the performance of their solar panels but also aims to make clean energy more affordable and accessible. By optimizing the design, Beamreach enables solar installers and commercial building owners to reduce installation time and labor costs associated with traditional solar panels and racking systems.

BrainCells

Series B in 2008
BrainCells develops and provides biopharmaceutical products for the treatment of central nervous system (CNS) diseases. It develops compounds that promote the growth of new neurons for the treatment of major depressive disorder (MDD), treatment resistant depression (TRD), and potentially Alzheimer’s disease (AD). The company's products include BCI-838 and BCI-632 which increase synaptic glutamate by inhibiting the mGlu2/3 auto-receptor. The company also builds a pipeline of clinical-stage programs to address unmet medical needs in the treatment of mood disorders, psychoses, cognition, brain repair syndromes, and other CNS disorders. The company was founded in 2003 and is based in San Diego, California.

Revance Therapeutics

Series C in 2007
Revance Therapeutics is a biopharmaceutical company focused on developing and commercializing products for dermatology and aesthetics. Its lead product, RT001, is a topical botulinum toxin type A for cosmetic use, hyperhidrosis treatment, and other dermatological indications.

Imperium Renewables

Series B in 2007
Imperium Renewables, Inc. is a producer and marketer of biodiesel in the United States, utilizing feedstock oils and glycerin, a by-product of biodiesel production. Established in 2004 and based in Seattle, Washington, the company operates BQ-9000-certified biodiesel facilities in Hoquiam, Washington, and Oahu, Hawaii. Its biodiesel serves as an alternative fuel for various modes of transportation, including cars, trucks, ships, trains, and planes. Imperium Renewables markets its products through a network of distributors, emphasizing its commitment to renewable energy solutions. The company was formerly known as Seattle Biodiesel, LLC before rebranding in May 2005.

ITM Software

Venture Round in 2007
ITM Software is a provider of IT Business Management solutions that focuses on delivering an integrated approach to enhance visibility, coordination, and control across various IT functions. The company offers the ITM Business Suite, a comprehensive software solution comprising multiple modules that address critical areas such as human resources, processes, vendors, assets, financials, projects, and regulatory compliance. Founded in 2001 by former CIOs and IT leaders, ITM Software aims to bridge the traditional silos of IT information, facilitating increased transparency and better decision-making for its clients. The company serves IT organizations within Fortune 2000 corporations, government agencies, and universities, delivering both software products and best-practice expertise to help clients define their business objectives and implement effective strategies. Headquartered in Mountain View, California, ITM Software is privately held and focuses on improving business alignment and reducing IT costs for enterprises.

Leptos Biomedical

Series C in 2007
Leptos Biomedical is a company that specializes in developing innovative neuromodulation therapy solutions for chronic obesity. Founded in 2002 and headquartered in Fridley, Minnesota, the company has created a treatment that operates through the electrical activation of a specific nerve within the autonomic nervous system, utilizing a device similar to a pacemaker. This proprietary approach aims to address the complexities of obesity by targeting the underlying neurological factors contributing to the condition.

Tria Beauty

Series D in 2007
TRIA Beauty, Inc. is a developer and marketer of light-based medical devices aimed at the consumer market, specializing in beauty and skincare solutions. Founded in 2003 and headquartered in Dublin, California, the company offers a range of innovative products including a hand-held, cordless diode laser for hair removal, a Skin Perfecting Blue Light device for acne treatment, a Skin Rejuvenating Laser for anti-aging purposes, and an Age-Defying Eye Wrinkle Correcting Laser. These devices utilize advanced light technology, which is preferred by dermatologists for effective skincare treatments, allowing users to achieve professional results at home. TRIA Beauty products are available through its e-commerce platform and various indirect sales channels, including retail outlets, television, and physician offices. The company serves a global market, reaching customers in the United States, Japan, South Korea, Canada, the United Kingdom, Germany, and Spain.

Tesla

Series D in 2007
Tesla designs and manufactures electric vehicles and energy generation and storage systems, pursuing a vertically integrated approach to product and software development. It offers a full range of electric cars, including sedans and crossover models, and markets its vehicles through company-owned stores and its website. The company also produces and sells stationary energy storage batteries for residential, commercial, and utility use, and provides solar energy generation and solar storage products. It operates a fast-charging network and develops autonomous driving software. Headquartered in Palo Alto, California, Tesla serves international markets and aims to accelerate the transition to sustainable mobility through innovation across vehicles, energy, and software.

Nfocus Neuromedical

Series B in 2007
Nfocus Neuromedical, Inc. designs, develops, and markets endovascular neurosurgery solutions to cure intracranial aneurysms. The company offers revolutionary systems to treat neurovascular disease, including brain aneurysms. The company was formerly known as CardioVasc, Inc. and changed its name to Nfocus Neuromedical, Inc. in April 2007. The company was incorporated in 1997 and is based in Palo Alto, California. As of February 19, 2013, Nfocus Neuromedical, Inc. operates as a subsidiary of Covidien plc.

Accelergy

Series B in 2006
Accelergy Corporation, established in 2003 and based in Houston, Texas, specializes in producing low-carbon synthetic distillate liquids and transportation fuels. The company employs Hydroconversion technologies to transform abundant natural resources like natural gas, biomass, and coal into clean specialty products and fuels, with a reduced carbon footprint compared to traditional petroleum-based alternatives. Accelergy's strategic alliance with Owensboro Grain LLC supports its global operations, serving energy and specialty product markets worldwide.

PowerGenix

Series C in 2006
PowerGenix is a manufacturer of nickel-zinc rechargeable batteries designed for mission-critical applications. The company's products are utilized in a variety of sectors, including data centers, intelligent transportation, cordless power tools, hybrid electric vehicles, uninterruptible power supply (UPS) systems, personal mobility devices, and military and medical devices. By focusing on sustainable battery technology, PowerGenix aims to provide reliable and efficient power solutions for diverse applications, contributing to advancements in energy storage and management.

CoalTek

Series B in 2006
CoalTek, Inc. specializes in the production of high-quality coal by converting lower-grade coal into a cleaner energy fuel with reduced environmental impact. Founded in 1998 and headquartered in Tucker, Georgia, the company employs a proprietary volumetric heating process that targets moisture within the coal, utilizing 50-70 percent less energy compared to traditional thermal methods. This technology, developed over eight years by co-founder Dr. Jerry Weinberg and chief geologist Neil Ginther, effectively reduces the moisture content in various types of coal, enhancing plant efficiency and ensuring compliance with environmental standards. CoalTek opened its first commercial processing facility in Calvert City, Kentucky, in 2006, with an initial capacity of 120,000 tons per year, and plans for future expansions and additional facilities to meet the increasing demand for clean coal solutions.

BioTrove

Venture Round in 2006
BioTrove, Inc. specializes in micro and nano-scale technology platforms designed for life science research and drug discovery. The company offers several key products, including OpenArray, which facilitates relative gene expression analysis and supports genomic research across various fields such as agriculture, disease research, and public health. Additionally, BioTrove provides the RapidFire platform, enabling the screening of difficult drug targets through mass spectrometry-based assay development, along with the RapidFire mass spectrometry hardware system, which serves as a detection technology for drug screening and in vitro ADME applications. Their innovative systems consist of laboratory instruments and consumables that enhance the efficiency of genomic analysis, high-throughput screening, and molecular diagnostics, thereby accelerating research processes and development across multiple scientific domains.

NanoGram

Venture Round in 2006
NanoGram Corporation is a nanotechnology company that develops and manufactures products for advanced applications in photovoltaics, electronics, and displays. It offers a customized application-specific nanotechnology platform that provides tailored nanoscale compositions for various industries, including optical, electronic, imaging, biomedical, and energy sectors. The company has successfully incubated and spun out two notable entities, NeoPhotonics and NanoGram Devices. With offices in Tokyo and Seoul, NanoGram enhances its presence in Asia through strategic partnerships, including a collaboration with Nagase & Co., Ltd/Nagase ChemteX Corporation, facilitating development and manufacturing supply relationships in Japan and addressing expanding market opportunities in Korea.

eNeura Therapeutics

Series B in 2005
eNeura Inc. is a medical technology company focused on developing portable, non-invasive transcranial magnetic stimulation (TMS) devices for the treatment and prevention of migraines. Its flagship product, the sTMS mini, utilizes single-pulse TMS to provide migraine relief by generating targeted magnetic fields that pass through bone and tissue. This device is designed for both acute and prophylactic treatment of migraines in adolescents aged 12 and older, as well as adults, allowing for convenient use at home or on the go. eNeura was established in 2012 and is headquartered in San Jose, California, with an additional office in Baltimore, Maryland. The company, formerly known as eNeura Therapeutics LLC, rebranded in February 2014. However, it faced financial difficulties and filed for liquidation under Chapter 7 in August 2020.

Sensicore

Series C in 2005
Sensicore, Inc. is a manufacturer and developer of smart sensor systems and sensor networks, headquartered in Ann Arbor, Michigan. The company specializes in automating water testing, data collection, and analysis for both drinking and industrial applications. Its flagship products include WaterPOINT, a handheld water tester that provides a comprehensive profile of various chemistry measurements, and WaterNOW, a web-based data visualization and decision support system for managing water systems. Sensicore also offers a variety of sensor kits and bundles designed for disinfection and basic water testing, alongside colorimetric test kits that measure a range of water quality parameters. Additionally, the company provides accessories such as portable thermal printers and power supply products to enhance its testing solutions. Sensicore's products serve multiple applications, including monitoring incoming water quality, cooling tower processes, and filtration system performance. Founded in 2000, Sensicore operates as a subsidiary of GE Analytical Instruments, Inc. as of 2008.

CoalTek

Series A in 2005
CoalTek, Inc. specializes in the production of high-quality coal by converting lower-grade coal into a cleaner energy fuel with reduced environmental impact. Founded in 1998 and headquartered in Tucker, Georgia, the company employs a proprietary volumetric heating process that targets moisture within the coal, utilizing 50-70 percent less energy compared to traditional thermal methods. This technology, developed over eight years by co-founder Dr. Jerry Weinberg and chief geologist Neil Ginther, effectively reduces the moisture content in various types of coal, enhancing plant efficiency and ensuring compliance with environmental standards. CoalTek opened its first commercial processing facility in Calvert City, Kentucky, in 2006, with an initial capacity of 120,000 tons per year, and plans for future expansions and additional facilities to meet the increasing demand for clean coal solutions.

ITM Software

Venture Round in 2005
ITM Software is a provider of IT Business Management solutions that focuses on delivering an integrated approach to enhance visibility, coordination, and control across various IT functions. The company offers the ITM Business Suite, a comprehensive software solution comprising multiple modules that address critical areas such as human resources, processes, vendors, assets, financials, projects, and regulatory compliance. Founded in 2001 by former CIOs and IT leaders, ITM Software aims to bridge the traditional silos of IT information, facilitating increased transparency and better decision-making for its clients. The company serves IT organizations within Fortune 2000 corporations, government agencies, and universities, delivering both software products and best-practice expertise to help clients define their business objectives and implement effective strategies. Headquartered in Mountain View, California, ITM Software is privately held and focuses on improving business alignment and reducing IT costs for enterprises.

NeuroPace

Venture Round in 2005
NeuroPace designs and markets implantable neuromodulation systems for neurological disorders, with a focus on epilepsy. Its flagship RNS System includes an implantable neurostimulator connected to depth and cortical leads that monitor brain activity and deliver targeted, responsive electrical stimulation to seizure onset regions. External components, including a programmer and software, enable device configuration and monitoring. Founded in 1997 and based in Mountain View, California, the company generates most revenue from selling RNS Systems to hospital facilities for implantation in patients with medically refractory partial epilepsy. NeuroPace aims to reduce or eliminate seizures through adaptive neuromodulation.

PolyFuel

Series C in 2004
PolyFuel, Inc. is a company that specializes in the design, development, engineering, and manufacturing of portable fuel cells aimed at powering electronic devices. Founded in 1999 and based in Mountain View, California, PolyFuel focuses on creating advanced membranes and systems to address the power limitations faced by portable electronics. Through its innovative approach, the company seeks to enhance the performance and efficiency of fuel cell technology, contributing to the advancement of energy solutions for various electronic applications.

Revance Therapeutics

Series B in 2004
Revance Therapeutics is a biopharmaceutical company focused on developing and commercializing products for dermatology and aesthetics. Its lead product, RT001, is a topical botulinum toxin type A for cosmetic use, hyperhidrosis treatment, and other dermatological indications.

Accelergy

Series A in 2004
Accelergy Corporation, established in 2003 and based in Houston, Texas, specializes in producing low-carbon synthetic distillate liquids and transportation fuels. The company employs Hydroconversion technologies to transform abundant natural resources like natural gas, biomass, and coal into clean specialty products and fuels, with a reduced carbon footprint compared to traditional petroleum-based alternatives. Accelergy's strategic alliance with Owensboro Grain LLC supports its global operations, serving energy and specialty product markets worldwide.

Saegis Pharmaceuticals

Series B in 2003
Saegis Pharmaceuticals, established in 1999 and headquartered in Half Moon Bay, California, specializes in the development of medicines targeting cognitive dysfunction related to various central nervous system diseases. Its pipeline focuses on conditions such as Alzheimer's disease, mild cognitive impairment, attention deficit hyperactivity disorder, and cognitive impairment associated with schizophrenia. The company aims to improve memory loss and cognition deficits stemming from aging, psychiatric disorders, and brain trauma through its CNS therapeutics.

ITM Software

Series B in 2003
ITM Software is a provider of IT Business Management solutions that focuses on delivering an integrated approach to enhance visibility, coordination, and control across various IT functions. The company offers the ITM Business Suite, a comprehensive software solution comprising multiple modules that address critical areas such as human resources, processes, vendors, assets, financials, projects, and regulatory compliance. Founded in 2001 by former CIOs and IT leaders, ITM Software aims to bridge the traditional silos of IT information, facilitating increased transparency and better decision-making for its clients. The company serves IT organizations within Fortune 2000 corporations, government agencies, and universities, delivering both software products and best-practice expertise to help clients define their business objectives and implement effective strategies. Headquartered in Mountain View, California, ITM Software is privately held and focuses on improving business alignment and reducing IT costs for enterprises.

Sensicore

Series B in 2003
Sensicore, Inc. is a manufacturer and developer of smart sensor systems and sensor networks, headquartered in Ann Arbor, Michigan. The company specializes in automating water testing, data collection, and analysis for both drinking and industrial applications. Its flagship products include WaterPOINT, a handheld water tester that provides a comprehensive profile of various chemistry measurements, and WaterNOW, a web-based data visualization and decision support system for managing water systems. Sensicore also offers a variety of sensor kits and bundles designed for disinfection and basic water testing, alongside colorimetric test kits that measure a range of water quality parameters. Additionally, the company provides accessories such as portable thermal printers and power supply products to enhance its testing solutions. Sensicore's products serve multiple applications, including monitoring incoming water quality, cooling tower processes, and filtration system performance. Founded in 2000, Sensicore operates as a subsidiary of GE Analytical Instruments, Inc. as of 2008.

Storability Software

Series D in 2003
Storability Software specializes in enterprise storage resource management solutions designed to streamline and centralize the administration of complex, multi-site, and multi-vendor storage infrastructures. Its flagship product, the Global Storage Manager, is an open standards-based solution that empowers organizations to better understand and manage their storage assets. By utilizing Storability Software's offerings, customers experience enhanced asset utilization, improved management efficiency, superior service quality, and increased availability of their storage resources. The company's focus on simplifying storage management allows clients to maximize their investment in storage technology.

Rinat Neuroscience

Series B in 2003
Rinat Neuroscience, established in 2001 as a spin-out from Genentech, specializes in the development of protein-based therapeutics targeting diseases and disorders of the nervous system. The company leverages over 15 years of research and development support from Genentech to advance its innovative pipeline. Rinat focuses on creating antibody drugs for various conditions, including pain, Alzheimer's disease, obesity, diabetes, and neuropathies. In addition to these therapeutic areas, Rinat is engaged in developing novel disease-modifying therapies aimed at modulating neuronal function and preventing or reversing damage to specific populations of neurons affected by these diseases.

Iomai

Series C in 2003
Iomai Corporation, established in 1997 and headquartered in Gaithersburg, Maryland, specializes in the discovery and development of vaccines and immune system stimulants. The company's unique approach involves a needle-free delivery method known as transcutaneous immunization (TCI), which harnesses the skin's antigen-presenting cells to generate an enhanced immune response. Iomai leverages this technology to improve existing vaccines, enable new ones, and expand global vaccine accessibility. Following its acquisition by Intercell AG in 2008, Iomai operates as a subsidiary under the name Intercell USA Inc.

Datria Systems

Series C in 2002
Datria Systems specializes in voice-enabled enterprise mobility solutions that enhance communication and information exchange within organizations. The company’s software allows users to utilize their existing phones or VoIP-capable devices to interact in real-time with central corporate systems. By facilitating two-way voice communication, Datria's products enable seamless information flow between central offices and field representatives, effectively integrating voice capabilities into existing business processes. This innovative approach enhances productivity and improves operational efficiency across various industries.

PolyFuel

Series B in 2002
PolyFuel, Inc. is a company that specializes in the design, development, engineering, and manufacturing of portable fuel cells aimed at powering electronic devices. Founded in 1999 and based in Mountain View, California, PolyFuel focuses on creating advanced membranes and systems to address the power limitations faced by portable electronics. Through its innovative approach, the company seeks to enhance the performance and efficiency of fuel cell technology, contributing to the advancement of energy solutions for various electronic applications.

Storability Software

Series C in 2002
Storability Software specializes in enterprise storage resource management solutions designed to streamline and centralize the administration of complex, multi-site, and multi-vendor storage infrastructures. Its flagship product, the Global Storage Manager, is an open standards-based solution that empowers organizations to better understand and manage their storage assets. By utilizing Storability Software's offerings, customers experience enhanced asset utilization, improved management efficiency, superior service quality, and increased availability of their storage resources. The company's focus on simplifying storage management allows clients to maximize their investment in storage technology.

eNeura Therapeutics

Series A in 2002
eNeura Inc. is a medical technology company focused on developing portable, non-invasive transcranial magnetic stimulation (TMS) devices for the treatment and prevention of migraines. Its flagship product, the sTMS mini, utilizes single-pulse TMS to provide migraine relief by generating targeted magnetic fields that pass through bone and tissue. This device is designed for both acute and prophylactic treatment of migraines in adolescents aged 12 and older, as well as adults, allowing for convenient use at home or on the go. eNeura was established in 2012 and is headquartered in San Jose, California, with an additional office in Baltimore, Maryland. The company, formerly known as eNeura Therapeutics LLC, rebranded in February 2014. However, it faced financial difficulties and filed for liquidation under Chapter 7 in August 2020.

NightFire Software

Series D in 2002
NightFire Software specializes in providing order management software designed to automate the telecommunications service supply chain. Their solutions streamline interactions between retailers and wholesalers of telecommunications services, enabling providers to deliver services efficiently and cost-effectively in a deregulated market. The company's flagship product, NetServ Express, automates the entire ordering process for competitive service providers, ensuring high-quality service at minimal cost while reducing management burdens on incumbent providers. Additionally, NightFire offers a range of support services including customer environment analysis, software installation, connectivity testing, and ongoing technical support to ensure seamless operations.

Storability Software

Series B in 2001
Storability Software specializes in enterprise storage resource management solutions designed to streamline and centralize the administration of complex, multi-site, and multi-vendor storage infrastructures. Its flagship product, the Global Storage Manager, is an open standards-based solution that empowers organizations to better understand and manage their storage assets. By utilizing Storability Software's offerings, customers experience enhanced asset utilization, improved management efficiency, superior service quality, and increased availability of their storage resources. The company's focus on simplifying storage management allows clients to maximize their investment in storage technology.

Spinal Dynamics

Series B in 2001
Spinal Dynamics develops neuro-surgical devices for the replacement of spinal disks. The company's Bryan Cervical Disc System is an implanted prosthesis designed to replace and mimic the flexibility and shock-absorbing characteristics of natural intervertebral discs. It features a shock-absorbing elastomer that is intended to cushion the vertebrae and allow movement of the head and neck and is designed to replace the disc that is removed from the patient in cervical spine surgery.

Rinat Neuroscience

Series A in 2001
Rinat Neuroscience, established in 2001 as a spin-out from Genentech, specializes in the development of protein-based therapeutics targeting diseases and disorders of the nervous system. The company leverages over 15 years of research and development support from Genentech to advance its innovative pipeline. Rinat focuses on creating antibody drugs for various conditions, including pain, Alzheimer's disease, obesity, diabetes, and neuropathies. In addition to these therapeutic areas, Rinat is engaged in developing novel disease-modifying therapies aimed at modulating neuronal function and preventing or reversing damage to specific populations of neurons affected by these diseases.

APX

Series C in 2000
APX, Inc., founded in 1996 and based in San Jose, California, specializes in providing software solutions for the energy and environmental markets. The company offers a range of infrastructure solutions, including environmental asset management, renewable energy certificate creation and transactions, greenhouse gas offset tracking, demand response systems, and supervisory control and data acquisition solutions. APX also provides services such as real-time agent support, transaction management, resource control, and helpdesk services. Additionally, the company offers MarketSuite solutions for scheduling, operations, settlement processes, and third-party integrations related to ISO market participation and demand response programs. With a focus on innovation and deep domain expertise, APX delivers technology and service solutions that ensure trust, integrity, and experience in the energy and environmental sectors.

Encirq Corporation

Venture Round in 2000
Encirq solves marketing's #1 challenge: Delivering Personalization with Privacy™. Encirq is an online marketing services company that has developed a unique data engine to deliver individualized, consumer-centered marketing over the Internet. We use online and offline, real-time individual transactional data in a private and secure environment. Marketers and Encirq cannot see the data. Rather, the data reside on each consumer's personal computer, and filter out marketing messages that are not relevant. The service and technology are extendible to broadband, to other network devices, and eventually can be used to deliver personalized television commercials to individual households. Encirq's data engine does two things: It provides cost-effective access to consumer information not previously available; and it enables personalized real-time marketing programs. We have filed multiple patent applications on Encirq's illumination processes and technology.

APX

Series C in 2000
APX, Inc., founded in 1996 and based in San Jose, California, specializes in providing software solutions for the energy and environmental markets. The company offers a range of infrastructure solutions, including environmental asset management, renewable energy certificate creation and transactions, greenhouse gas offset tracking, demand response systems, and supervisory control and data acquisition solutions. APX also provides services such as real-time agent support, transaction management, resource control, and helpdesk services. Additionally, the company offers MarketSuite solutions for scheduling, operations, settlement processes, and third-party integrations related to ISO market participation and demand response programs. With a focus on innovation and deep domain expertise, APX delivers technology and service solutions that ensure trust, integrity, and experience in the energy and environmental sectors.

SkillsVillage

Series B in 2000
SkillsVillage is a provider of online recruitment services specializing in the procurement of skilled professionals, particularly in the information technology sector. The company offers a comprehensive platform that facilitates the entire procurement lifecycle, allowing businesses to efficiently find, hire, and manage contract workers. SkillsVillage's eMarketplace effectively matches available skills with specific business needs, enhancing the recruitment process. Additionally, the company delivers a network of qualified professionals alongside robust resource management tools, including a distinctive contractor rating system that integrates smoothly into existing corporate infrastructures. SkillsVillage also supports organizations with hosted solutions and services for skills sourcing, procurement, fulfillment, and supplier network management, streamlining operations and optimizing business processes.

ELoan

Post in 2000
E-LOAN is a nationwide financial services company established in 1997, focused on providing consumers with straightforward access to high yield savings accounts and certificates of deposit (CDs). The company offers a platform that connects users with various nationally recognized lending partners, helping them find loans tailored to their financial needs. E-LOAN emphasizes pro-consumer values, aiming to enhance the online experience for its customers through a simple and effective financial research platform, complemented by educational tools and resources.

Imagicast

Series C in 2000
Imagicast, Inc. specializes in strategic merchandising solutions tailored for the retail sector. The company offers a one-to-one merchandising platform that integrates marketing, e-commerce, and business intelligence functionalities. This platform empowers retailers and brand manufacturers to create engaging in-store product demonstrations and personalized promotions. Additionally, it enables the collection of valuable insights into customer shopping and purchasing behaviors, helping clients enhance their ability to convert shoppers into buyers.

AllAdvantage

Venture Round in 2000
As of January 2001, AllAdvantage Inc. went out of business. AllAdvantage.com, Inc. operates as an Internet advertising company. It pays its users/members a portion of the advertising revenue generated by their online viewing habits. The company also allows members to receive membership benefits that include sponsor discounts and rebates for surfing the Web. In addition, it provides incentives for advertisers to build one-on-one relationships with its members. The company was founded in 1999 and is based in Hayward, California with additional offices in Atlanta, Boston, Chicago, Dallas, Detroit, Hayward, London, Los Angeles, New York, Paris, Seattle, Sydney, and Washington DC.

HeartStent

Venture Round in 1999
HeartStent is a cardiovascular device firm. It is a direct revascularization device intended for coronary artery disease patients currently treated with coronary artery bypass grafts.

Spinal Dynamics

Series A in 1997
Spinal Dynamics develops neuro-surgical devices for the replacement of spinal disks. The company's Bryan Cervical Disc System is an implanted prosthesis designed to replace and mimic the flexibility and shock-absorbing characteristics of natural intervertebral discs. It features a shock-absorbing elastomer that is intended to cushion the vertebrae and allow movement of the head and neck and is designed to replace the disc that is removed from the patient in cervical spine surgery.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.